Regulates the nonprescription sales of ephedrine, pseudoephedrine, and phenylpropanolamine.

Requires the board of pharmacy to implement a real-time electronic sales tracking system to monitor the nonprescription sale of products in this state containing any detectable quantity of ephedrine, pseudoephedrine, phenylpropanolamine, or their salts, isomers, or salts of isomers, provided that the system is available to the state without cost to the state or retailers for accessing the system.

Requires a purchaser to electronically or manually sign a record of a sales transaction.

Requires submission of certain information to the electronic sales tracking system before completing a sale.